Giovanna Marrapese
机构: Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy
每年引用次数
引用次数
引用: 4,200
H-指数: 16
I10-指数 : 17
出版物: 38
Phase II study of temozolomide (TMZ) in metastatic colorectal cancer (mCRC) patients molecularly selected by MGMT promoter hypermethylation.
Alessio Amatu , Katia Bencardino , Ludovic Barault , Andrea Cassingena
Journal of Clinical Oncology 33 583 -583
2
2015
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
Andrea Sartore-Bianchi , Elena Ardini , Roberta Bosotti , Alessio Amatu
Journal of the National Cancer Institute 108 ( 1) 1 -4
186
2016
Phase II study of dacarbazine for metastatic colorectal cancer with determined MGMT status.
Alessio Amatu , Andrea Sartore-Bianchi , Katia Bencardino , Catia Moutinho
Journal of Clinical Oncology 30 3570 -3570
2012
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Alessio Amatu , Alessio Somaschini , Giulio Cerea , Roberta Bosotti
British Journal of Cancer 113 ( 12) 1730 -1734
46
2015
Cardiotoxicity of novel molecular targeted therapies of cancer
Sara Di Bella , Filippo Venturini , Giovanna Marrapese , Emiliana Tarenzi
Journal of Cardiovascular Echography 21 ( 2) 78 -85
2011
Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
Andrea Sartore-Bianchi , Federica Di Nicolantonio , Michele Nichelatti , Francesca Molinari
PLoS ONE 4 ( 10) e7287 -7287
307
2009
EGFR FISH analysis in colorectal cancer as a tool in selecting patients for antiEGFR monoclonal antibodies therapy
Mauro Moroni , Giovanna Marrapese , Silvio Veronese
Oncology Reviews 3 ( 3) 187 -193
1
2011
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Sandro Pignata , Giovanni Scambia , Clorinda Schettino , Laura Arenare
The Lancet Oncology 24 ( 3) 286 -296
1
2023
Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
Salvatore Siena , Mauro Moroni , Giovanna Marrapese , Andrea Sartore-Bianchi
8
2009
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report
Elio Gregory Pizzutilo , Alberto Giuseppe Agostara , Laura Roazzi , Rebecca Romanò
JTO Clinical and Research Reports 4 ( 11) 100555 -100555
3
2023
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers
Gianluca Mauri , Giorgio Patelli , Laura Roazzi , Emanuele Valtorta
Journal of Clinical Pathology
2024
Abstract CT215: Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer
Silvia Marsoni , Giovanni Germano , Andrea Sartore Bianchi , Filippo Pietrantonio
Cancer Research 79 ( 13_Supplement) CT215 -CT215
2019
CONCOMITANT ANALYSIS OF KRAS, BRAF, PIK3CA MUTATIONS AND LOSS OF PTEN EXPRESSION ENHANCES PREDICTION OF CLINICAL OUTCOME TO CETUXIMAB OR PANITUMUMAB IN METASTATIC COLORECTAL CANCER
Salvatore Siena , Andrea Sartore-Bianchi , Federica Di Nicolantonio , Michele Nichelatti
ANNALS OF ONCOLOGY 20
2009
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
M Reni , E Giommoni , F Bergamo , M Milella
ESMO open 8 ( 1) 100777 -100777
2
2023
Phase 1 open label, dose escalation study of RXDX101, an oral pan-trk, ROS1, and ALK inhibitor, in patients with advanced solid tumors with relevant molecular alterations
Filippo G De Braud , Lorenzo Pilla , Monica Niger , Silvia Damian
J Clin Oncol 32 ( suppl 5) 2502a -2502a
51
2014
First-line single-agent cetuximab in patients with advanced colorectal cancer
A. Pessino , S. Artale , A. Guglielmi , S. Sciallero
Journal of Clinical Oncology 24 ( 18_suppl) 3553 -3553
2
2006
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
A. Amatu , L. Barault , C. Moutinho , A. Cassingena
Annals of Oncology 27 ( 6) 1062 -1067
36
2016
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.
A. Sartore-Bianchi , G. Cerea , I. Schiavetto , L. Giannetta
Annals of Oncology 17
8
2006